Most Active Biotech Companies – MannKind Corporation (MNKD), Gilead Sciences (GILD) and Ariad Pharmaceuticals (ARIA)


On Friday, shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA). Last week it was revealed to Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) that European regulators asked the company to continue the use of Iclusig – company’s leukemia drug; Iclusig’s sales were stopped in the US because of some security concerns. FDA is having talks with Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) to revise the label of the drug. Shares of Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) started off at $4.44 and went up as high as $5.00 during the trading session and after going up by 6.61% towards the end of day’s trading closed at $4.84. The company’s stock has a 73.48% weekly performance.

Investors in Gilead Sciences, Inc. (NASDAQ:GILD) investors faced new possibilities for expiration of January 2014 at the start of today’s trading. At Stock Options Channel, GILD options were looked up by the YieldBoost formula for new contracts in January 2014; it specifically looked up one call and one put contract. Shares of Gilead Sciences, Inc. (NASDAQ:GILD) ended at $74.81 yesterday. Institutional ownership of the stock is 95.10% and its insider ownership is 0.30%. Stock’s share capital has outstanding shares of 1.53 billion out of which 1.52 billion are floating in the market.

MannKind Corporation (NASDAQ:MNKD) is focusing on discovery, development and commercialization of diabetes treatment. The company reported today that MannKind will be presenting at the “Piper Jaffray 25th Annual Healthcare Conference” that will be held on Wednesday at ET of 10:00 am; the conference will be held in New York at the “New York Palace”. Shares of MannKind Corporation (NASDAQ:MNKD) had a volume share of 2.85 million on the last day of trading; its average volume share is 4.19 million. Shares of MannKind Corporation (NASDAQ:MNKD) opened at $5.00 and went up as high as $5.03 and closed at $4.99.

Ariad Pharmaceuticals
Ariad Pharmaceuticals